Home / News / Archive by category "NZ News"

NZ News

Spot light on NZ MC companies – SOMA

Q1. Who are you, where are you based and what do you do? SOMA Group is New Zealand’s leading science-based medical cannabis company. The only end-to-end business in the market, we’re also the only science wholesaler with a national research programme collaborating with the University of Otago, and the only business focussed on matching whole plant and human genetics (endocannabinoids).Based...
Read More

Spot light on NZ MC companies – Rua Bioscience

Q1. Who are you, where are you based and what do you do? Rua Bioscience is a medicinal cannabis company from Tairāwhiti. Founded in 2016 initially as a subsidiary of charitable company Hikurangi Enterprises, Rua Bioscience aspires to be a global innovator in cannabis breeding and genetics, cultivation and product innovation. The company has two licensed cultivation sites near Ruatoria and a med...
Read More

Spot light on NZ MC companies – Puro

Q1. Who are you, where are you based and what do you do? Puro, Marlborough. Cultivation of cannabis and hemp for medical end use. Q2. Will you offer compassionate discounts, (community service card holders, pensioners etc)? Puro sell to pharmaceutical companies and extraction partners. We don’t sell direct to consumer. Q3. Do you have plans for trials regarding chronic pain? No. Q4. What c...
Read More

Spot light on NZ MC companies – NUBU Pharmaceuticals

NUBU Pharmaceuticals' logo
Q1. Who are you, where are you based and what do you do? My name is Mark Dye, and I am the CEO of Auckland based NUBU Pharmaceuticals. Q2. Will you offer compassionate discounts, (community service card holders, pensioners etc)? I am unable to answer this question as suppliers of unapproved medicines are unable to communicate in a manner that Medsafe would consider advertising. Sorry. Q3. Do...
Read More

Spot light on NZ MC companies – Medleaf Therapeutics

Q1. Who are you, where are you based and what do you do? Courtney Letica, Auckland, CEO of Medleaf Therapeutics Q2. Will you offer compassionate discounts, (community service card holders, pensioners etc)? We offer the best price to market and will continue to do so. This is our business model. Q3. Do you have plans for trials regarding chronic pain? No. Q4. What certification programs, i....
Read More

Spot light on NZ MC companies – Helius Therapeutics

Q1. Who are you, where are you based and what do you do? Helius is one of New Zealand’s largest licensed medical cannabis companies and we exist to improve quality of life. Our first priority is to provide high-quality, affordable medicinal cannabis to kiwi patients across the country.We have a bold vision, to become a world leader in the research and development of safe and efficacious med...
Read More

MCANZ Press Release: New Medical Cannabis Regulations “Bittersweet”

PRESS RELEASE:  Unveiling of Medical Cannabis regulations "Bittersweet" Today, the Medical Cannabis Regulations have been released, the reaction from patients has been mixed, with some excellent gains made around prescribers and access pathways, leaving the patients uphill battle for access squarely as a socio-economic issue.Prescribing Unleashed "The unleashing of GP Prescribing for is a gr...
Read More

MCANZ Press Release: Affordability needs addressing directly.

With the government's Medical Cannabis Scheme document out for consultation, Medical Cannabis Awareness NZ has undertaken an independent study of medicinal cannabis users. MCANZ, a charity which focuses on promoting access, supporting patients and providing education to the Medical profession, has received over 2,800 responses.Among the key interim findings is that one-third of medical users g...
Read More

MCANZ Press Release: Battle lines are drawn as Medical Cannabis prescribing restrictions universally derided

With the release of the Medical Cannabis Consultation paper, the most immediate contentious issue is prescribing.The Ministry's preferred solution is for GPs to prescribe unconsented/off-label only with the support of a specialist. This conflicts with the fact that those that are vocationally registered as GPs are considered specialists in General Practice. Various groups have expressed oppo...
Read More

The status of CBD in New Zealand

Late last year, Cannabidiol, or CBD for short was removed from the Misuse of Drugs Act as a schedule B drug.  This change had little practical changes for patients because Peter Dunne had removed a lot of Class Brequirements for CBD previously (he didn't seem to have authority to push through a full and proper descheduling). The key difference between CBD and other Cannabis products is tha...
Read More
Top